NDATOPICALGEL
Approved
Oct 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BENZAMYCIN (erythromycin and benzoyl peroxide) by Bausch + Lomb is clinical pharmacology the exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug. First approved in 1984.
Drug data last refreshed 18h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Benzamycin is a topical gel combination of erythromycin (antibiotic) and benzoyl peroxide (keratolytic agent) approved in 1984 for acne vulgaris. Erythromycin reduces acne lesions through antibacterial activity, while benzoyl peroxide provides keratolytic and desquamative effects. The synergistic dual mechanism addresses both bacterial and inflammatory components of acne pathogenesis.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), signaling potential team downsizing or redeployment for brand professionals.
Mechanism of Action
CLINICAL PHARMACOLOGY The exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug. Benzoyl peroxide has a keratolytic and desquamative effect which may also contribute to its…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Benzamycin offers experience in mature product management, dermatology marketing, and generic transition strategy within a stable but declining commercial environment. This role is best suited for professionals seeking to manage LOE challenges, market access optimization, and niche positioning rather than high-growth brand building.
Brand Manager
Worked on BENZAMYCIN at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.